Tuilleadh fiosrachaidh ― Scots gaelic

Mar as trice bidh Urticaria a’ nochdadh le welts àrd tachaiseach. Uaireannan bidh sèid anns na figheagan fon talamh còmhla ris. Tha làimhseachadh gu sònraichte a’ toirt a-steach a bhith a’ seachnadh luchd-brosnachaidh, ma tha fios air. Tha cungaidh-leigheis ciad loidhne a’ toirt a-steach antihistamines nas ùire, a ghabhas atharrachadh gu dòsan nas àirde ma tha feum air. Faodar cungaidhean eile leithid antihistamines nas sine, luchd-bacadh H2, antagonists receptor leukotriene, antihistamines nas làidire, agus cùrsaichean goirid de corticosteroids a chur ris mar thaic a bharrachd. Ann an cùisean far a bheil urticaria a’ leantainn a dh’aindeoin na ceumannan sin, dh’ fhaodadh euslaintich a bhith air an cur gu eòlaichean airson leigheasan a bharrachd leithid omalizumab no cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Tha an lèirmheas seo a’ mìneachadh an stiùireadh as ùire airson làimhseachadh urticaria agus a’ tabhann tuigse ùr air na h-adhbharan aige.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids